|
Bretylium Tosylate In Dextrose 5% In Plastic ContainerDrug - Bretylium Tosylate In Dextrose 5% In Plastic Container The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Bretylium Tosylate
Strength -
200MG/100ML
Applicant -
BAXTER HLTHCARE
New Drug Application (NDA) Number -
019837
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Apr 12, 1989
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Baxter Healthcare Corp
Bretylium Tosylate In Dextrose 5% In Plastic Container
Bretylium Tosylate 50mg/ml Injectable; Injection
Bretylium Tosylate In Dextrose 5% 200mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% 400mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% 800mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 100mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 200mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 400mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 200mg/100ml Injectable; Injection Bretylium Tosylate 50mg/ml Injectable; Injection Bretylium Tosylate 50mg/ml Injectable; Injection NewDrugInformation |